Related Experiment Video
Updated: Apr 7, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
8.2K
Should we screen for cognitive decline and dementia?
Laura Calzà1, Daniela Beltrami2, Gloria Gagliardi2
1Health Sciences and Technologies - Interdepartmental Center for Industrial Research (CIRI-SDV), University of Bologna, Italy; Pharmacy and Biotechnology (FaBiT), University of Bologna, Italy.
Maturitas
|July 9, 2015
Summary
Early detection of cognitive decline is crucial. New tools analyzing spontaneous speech may help differentiate serious neurodegeneration from normal aging or temporary issues.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Increasing life expectancy leads to a rise in cognitive decline cases.
- Early, personalized interventions can reduce the burden of cognitive decline.
- Distinguishing pathological decline from normal aging is a growing healthcare challenge.
Purpose of the Study:
- To redefine cognitive decline in relation to frailty.
- To explore ethical considerations in cognitive screening.
- To identify improved tools for detecting and differentiating cognitive decline.
- To assess the potential of speech analysis for cognitive assessment.
Main Methods:
- Reviewing international consensus on presymptomatic Alzheimer disease.
- Analyzing ethical issues in cognitive screening and counseling.
- Evaluating the need for sensitive and specific diagnostic tools.
- Investigating language and spontaneous speech analysis.
Main Results:
- Cognitive decline definitions need refinement alongside frailty.
- Ethical frameworks for cognitive screening require careful consideration.
- Enhanced sensitivity and specificity in diagnostic tools are essential.
- Spontaneous speech analysis shows promise for cognitive assessment.
Conclusions:
- Accurate identification of cognitive decline is vital for timely intervention.
- Ethical guidelines are necessary for cognitive screening programs.
- Advanced tools, including speech analysis, are needed to improve diagnosis.
- Further research into speech patterns can aid in understanding cognitive changes.
Keywords:
Cognitive declineCognitive frailtyOlder adultsPersonalized diagnosisScreeningSpontaneous speech analysisMore Related Videos
Related Concept Videos
01:30Dementia
721
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
721
01:30Cognitive Development During Adulthood
1.2K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
873
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
873
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K